Pharming Group N.V.
PHAR | NASDAQ
$12.23
+$0.10 (+0.82%)
At close: Oct 30, 2026, 4:00 PM ET
$12.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 146.02M | 56.89M | 61.74M | 207.34M | 217.59M | 167.94M |
Short-Term Investments | 33.79M | 116.96M | 151.68M | n/a | n/a | n/a |
Long-Term Investments | 9.87M | 4.38M | 10.4M | 9.73M | 9.81M | 5.83M |
Other Long-Term Assets | 93.98K | 2.52M | 1.62M | 1.33M | 1.14M | 30.98M |
Receivables | 54.69M | 51.95M | 42.62M | 25.33M | 31.28M | 19.25M |
Inventory | 64.88M | 57.7M | 56.76M | 42.33M | 30.96M | 17.32M |
Other Current Assets | 1K | n/a | n/a | 213K | 257.35K | 7.67M |
Total Current Assets | 299.38M | 288.32M | 316.34M | 277.5M | 282.8M | 215.47M |
Property-Plant & Equipment | 23.96M | 24.12M | 33.47M | 39.15M | 37.6M | 17.73M |
Goodwill & Intangibles | 135.5M | 63.21M | 71.27M | 75.12M | 95.04M | 72.55M |
Total Long-Term Assets | 200.43M | 125.86M | 146.51M | 148.3M | 167.64M | 127.08M |
Total Assets | 499.81M | 414.18M | 462.85M | 425.8M | 450.44M | 342.55M |
Account Payables | 105.87M | 10.46M | 16.02M | 8.75M | 8.62M | 11.03M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 5.34M | 4.4M | 1.82M | 1.77M | 2.13M | 1.67M |
Other Current Liabilities | 1.22M | 3.4M | n/a | n/a | n/a | 21.26M |
Total Current Liabilities | 115.79M | 76.42M | 77.97M | 59.7M | 53.02M | 62.91M |
Long-Term Debt | 92.72M | 80.93M | 136.6M | 131.62M | 157.59M | 122.57M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 187.06K | 173.54K |
Total Long-Term Liabilities | 107.07M | 108.85M | 166.11M | 161.46M | 178.7M | 129.48M |
Total Liabilities | 222.79M | 185.27M | 244.07M | 221.16M | 231.73M | 192.39M |
Total Debt | 115.78M | 116.3M | 171.55M | 166.69M | 183.39M | 132.58M |
Book Value | 277.02M | 228.91M | 218.78M | 204.64M | 218.71M | 150.16M |
Book Value Per Share | 3.88 | 3.32 | 3.33 | 2.43 | 2.50 | 1.85 |
Common Stock | 8.01M | 8.04M | 7.67M | 7.51M | 8.42M | 5.99M |
Retained Earnings | -272.9M | -285.27M | -265.26M | -256.43M | -309.69M | -221.85M |
Comprehensive Income | n/a | -216.42K | -2.06M | -8.74M | 3.85M | n/a |
Shareholders Equity | 277.02M | 228.91M | 218.78M | 204.64M | 218.71M | 150.16M |
Total Investments | 43.66M | 121.34M | 162.08M | 9.73M | 9.81M | 5.83M |
Add to Watchlist
Select watchlists to add or remove PHAR